|
|
|
|
Archives
|
Entry
|
Author
|
Date
|
Location
|
|
Quanterix Finds $6M
|
Erin Kutz |
08/23/11 |
Boston
|
|
Pulmatrix Snags $14M, Embera Adds for $4.5 Addiction Drugs, Daktari Gets $1.2M, & More Boston-Area Life Sciences News
|
Erin Kutz |
08/19/11 |
Boston
|
|
Carbonite Goes Public At $10 a Share, PeerTransfer Pulls In $7.5M, BuyWithMe Picks Up Scoop St., & More Boston-Area Deals News
|
Erin Kutz |
08/17/11 |
Boston
|
|
Pulmatrix Wins $14M to Back Drug For Cystic Fibrosis And Other Lung Ailments
|
Arlene Weintraub |
08/15/11 |
Boston
|
|
Pulmatrix Secures $14,000,000 Series B Funding
|
VentureDeal |
08/15/11 |
Boston
|
|
DuPont Scoops Up “Silicon Ink” Maker Innovalight
|
Wade Roush |
07/25/11 |
San Francisco
|
|
Sorbent Therapeutics Seeks to Fight Heart Failure in Unusual Arena: The Gut
|
Luke Timmerman |
07/13/11 |
San Francisco
|
|
The Missing Ingredient in Today’s Biotech: Guts
|
Luke Timmerman |
07/11/11 |
National
|
|
Fate Therapeutics Trims Chemistry Staff, Bets on Biotech Drugs
|
Luke Timmerman |
07/07/11 |
National
|
|
Cleantech-less in Seattle
|
Nikesh Parekh |
07/07/11 |
Seattle
|
|
Sorbent Therapeutics Absorbs $36M to Go After New Treatment For Kidney, Heart Failure
|
Luke Timmerman |
06/30/11 |
San Francisco
|
|
Sorbent Therapeutics Obtains $36,000,000 Series B Financing Round
|
VentureDeal |
06/30/11 |
San Francisco
|
|
Allozyne Acquires Poniard Pharmaceuticals, Finds Backdoor Route to NASDAQ
|
Luke Timmerman |
06/22/11 |
Seattle
|
|
Oncofactor Garners $2,100,000 Series A Financing Round
|
VentureDeal |
05/25/11 |
Seattle
|
|
Accelerator’s New Startup, Oncofactor, Seeks to Spark Immune System Fight Against Cancer
|
Luke Timmerman |
05/24/11 |
Seattle
|
|
Separating Hype from Reality in Alternative Fuels: the Photo Gallery
|
Curt Woodward |
05/20/11 |
Seattle
|
|
Electric Cars Won’t Take Over, Biofuels 3.0 Must Fix the Bugs, & Microorganisms as Problem-Solvers: Big Ideas from Cleantech Leaders
|
Curt Woodward |
05/20/11 |
Seattle
|
|
See You Tonight at “Separating Hype from Reality in Alternative Fuels”
|
Luke Timmerman |
05/19/11 |
Seattle
|
|
Bill Gates’ Favorite Biofuel Company on the Docket for Thursday’s Alternative Fuels Event
|
Luke Timmerman |
05/16/11 |
Seattle
|
|
Takeda Bets on Fate Therapeutics
|
Luke Timmerman |
05/10/11 |
San Diego
|
|
Kleiner Perkins’ Bet on a Concrete Stomach, The Gates Foundation’s Out-of-the-Box Ideas, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
05/05/11 |
Seattle
|
|
Blue Marble Energy Joins Ensemble Cast at Alternative Fuels Confab May 19
|
Luke Timmerman |
05/04/11 |
Seattle
|
|
What Do Amazon, Ezell’s, and Virginia Mason Have in Common? They Supply General Biodiesel
|
Luke Timmerman |
05/02/11 |
Seattle
|
|
Kilimanjaro Energy Seeks to Pop Loose Trillions’ Worth of Underground Oil, Save the World
|
Luke Timmerman |
05/02/11 |
San Francisco
|
|
PacBio Goes Commercial, Tweet by Tweet from BayBio, VCs Turn Up the Heat on FDA, & More Bay Area Life Sciences News
|
Luke Timmerman |
04/29/11 |
San Francisco
|
|
Turning Garbage Into Fuel, S4 Energy Joins Xconomy Lineup on May 19
|
Luke Timmerman |
04/28/11 |
Seattle
|
|
eBay Acquires Where, Bluebird Calls In $30M, Humedica Gets $20M, & More Boston-Area Deals News
|
Erin Kutz |
04/27/11 |
Boston
|
|
Bluebird Bio Snaps up $30M for Gene Therapies, Adds ARCH Venture to Syndicate
|
Ryan McBride |
04/20/11 |
Boston
|
|
bluebird bio Receives $30,000,000 Series C Financing Round
|
VentureDeal |
04/20/11 |
Boston
|
|
Separating Hype from Reality in Alternative Fuels: Slated for May 19 at Institute for Systems Biology
|
Luke Timmerman |
04/18/11 |
Seattle
|
|
Page 2 of
11 |
« previous page · next page » |
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.
© 2007-2012, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.
Site produced by Andrew Koyfman with design from Rob Hunter.